Chronic GVHD as an autoimmune disease
- 1 June 2008
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Haematology
- Vol. 21 (2) , 281-289
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host diseaseBlood, 2007
- Where FoxP3‐dependent regulatory T cells impinge on the development of inflammatory arthritisArthritis & Rheumatism, 2007
- T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritisJournal of Experimental Medicine, 2007
- Current status of lupus geneticsArthritis Research & Therapy, 2007
- Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT)Blood, 2006
- High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCTBlood, 2006
- Homeostatic Expansion of T Cells during Immune Insufficiency Generates AutoimmunityCell, 2004
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999
- Microchimerism and HLA-compatible relationships of pregnancy in sclerodermaThe Lancet, 1998